Medtronic plc logo

Medtronic plc

MDT
HealthcareNYSEIreland
86.88USD-0.29 (-0.33%)

About Medtronic

Medtronic plc is a global medical technology company that develops, manufactures, and sells a wide range of device-based medical therapies.

The company operates through four main segments:

  • Cardiovascular Portfolio: This includes implantable cardiac pacemakers, cardioverter defibrillators, cardiac ablation products, aortic and transcatheter valves, percutaneous coronary intervention products, and more. It also offers remote monitoring and patient-centered software solutions.

  • Medical Surgical Portfolio: Offers surgical stapling devices, vessel sealing instruments, electrosurgery products, hernia mechanical devices, and more. This segment also covers minimally invasive therapies for gastrointestinal and hepatologic conditions, as well as patient monitoring and airway management solutions.

  • Neuroscience Portfolio: Provides products for various specialists, including spinal and neurosurgeons, pain management specialists, and others. Offerings include image-guided surgery systems, intra-operative imaging, and robotic guidance systems for spine procedures.

  • Diabetes Operating Unit: Features insulin pumps, continuous glucose monitoring systems, and smart insulin pens, along with necessary consumables and supplies.

Founded in 1949, Medtronic is headquartered in Dublin, Ireland.

Medtronic's Business Strategy

Medtronic's core strategy is focused on maintaining its position as a global leader in healthcare technology by innovating, developing, manufacturing, and marketing a broad portfolio of medical devices and therapies. Their mission is to alleviate pain, restore health, and extend life across more than 70…

Available on Finplify

Free account required

Sign up free

Our Take on Medtronic

Pros:

MedTech Leader: Medtronic holds leading market share in heart devices, spinal products, insulin pumps, and chronic pain neuromodulators. This breadth provides resilience and exposure to multiple growth areas within healthcare.

Cardiac & Neuroscience Devices Position: The company maintains leading positions in cardiac rhythm…

Available on Finplify

Free account required

Sign up free

Company Details

Exchange
NYSE
Country
Ireland
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha
Employees
95,000
IPO Date
1973-05-02
ISIN
IE00BTN1Y115
Website
medtronic.com

Key Metrics

Market Cap
111.54BUSD
P/E Ratio (TTM)
24.22
Net Profit Margin
13.00%
Debt / Asset Ratio
0.31
Dividend Yield (TTM)
3.25%
Volume
634,481
Avg Volume
7.74M
Shares Outstanding
1.28B
Free Float
99.77%
β Beta
0.72
52W Range
79.5 - 106.3

Fundamental Analysis

Proprietary 5-category scoring system

Score Fingerprint

Section Scores

Profitability
3.5/5Good
Liquidity
3.8/5Good
Leverage
4.0/5Good
Cash Flow
4.5/5Excellent
Valuation
4.0/5Good

Full Breakdown & Peer Ranking

See the detailed score for every metric and how this stock ranks against its sector peers

Unlock for free
Free to join

Unlock the full research on Medtronic

Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.

300+ Curated Stocks

A hand-picked universe of world-class businesses across every major market and sector.

AI Analyst Briefings

Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.

Proprietary Fundamentals

Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.